As MedSurg demand rises, Boston Scientific and Medtronic compete for dominance. Which stock shows stronger growth momentum now?

Abbott Laboratories flexes its market muscle with consistent gains and an enviable track record of long-term growth. Its ...

Boston Scientific’s Neuromodulation segment is charging ahead with a caffeinated jolt of momentum, posting 6.8% operational ...

Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement ...

Medtronic (NYSE: MDT) + today announced that it issued a voluntary recall notification related to specific Newport ventilators and related service parts. The voluntary recall — labeled Class I ...

Scott Stanslaski, a senior distinguished engineer at Medtronic, will discuss the company’s DBS advances at DeviceTalks Minnesota, June 11, 2025, at the University of Minnesota’s McNamara ...

In 2006 executives within the Neurological division at Medtronic were trying to determine how to get a new innovative deep brain stimulation therapy to a standard of care. Medtronic had been very ...

Delegates to a United Nations meeting on neurotechnology ethics have devised the first set of global guidelines on maintaining users’ privacy.

Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient last month and recorded neural activity, before removing it 10 minutes ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...